Gonococcal antimicrobial resistance: Perspectives from the African region

Sexually Transmitted Infections

Volumn 89, Issue SUPPL. 4, 2013, Pages

  Ndowa, Francis J ^a,c   Francis, Joel M ^b   Machiha, Anna ^c   Faye Kette, Hortense ^d   Fonkoua, Marie Christine ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^d Institut Pasteur de Côte d'Ivoire   (Cameroon)

^e CENTRE PASTEUR DU CAMEROUN   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPECTINOMYCIN; TETRACYCLINE;

AFRICA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CIRCUMCISION; DISK DIFFUSION; EPSILOMETER TEST; GONORRHEA; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; SYPHILIS; TRICHOMONAS VAGINALIS; ULCUS MOLLE; URETHRAL DISCHARGE; URETHRITIS; WORLD HEALTH ORGANIZATION; ZIMBABWE;

AFRICA; ANTIMICROBIAL RESISTANCE; NEISSERIA GONORRHOEA;

AFRICA; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE;

EID: 84891865796     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050907     Document Type: Article

References (18)

1. World Health Organization. WHO Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: World Health Organization, 2012. http://www.who.int/reproductivehealth/publications/rtis/ 2008-STI-estimates. pdf
2. Lewis DA, Scott L, Slabbert M, et al. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: Association with HIV seropositivity. Sex Transm Infect 2008;84:352-5.
3. Antimicrobial Survey City of Harare-presentation at the 2012 Zimbabwe STI Update (Ms. Machiha). http://www.stdpreventiononline.org/index.php/resources/ resources/(accessed 21 Mar 2013).
4. Lewis DA, Sriruttan C, Coetzee J. Detection of multidrug-resistant gonorrhoea in the Gauteng province. South Afr J Epidemiol Infect 2012;27:199-200.
5. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 2010;15:pii = 19721.
6. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011;16:pii = 19792.
7. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: Time for a pharmacodynamics rethink? J Antimicrob Chemother 2010;65:2141-8.
8. World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: World Health Organization, 2012. ISBN: 978 92 4 150350 1.
9. Steen R. Eradicating chancroid. Bull World Health Organ 2001;79:818-26. (Pubitemid 32896104)
10. Steen R, Vuylsteke B, DeCoito T, et al. Evidence of declining STD prevalence in a South African mining community following a co-group intervention. Sex Transm Dis 2000;27:1-8. (Pubitemid 30058896)
11. Cao V, Ratsima E, Van Tri D, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, VietNam. Sex Trans Dis 2008;35:941-5.
12. Olsen B, Månsson F, Camara C, et al. Phenotypic and genetic characterisation of bacterial sexually transmitted infections in Bissau, Guinea-Bissau, West Africa: A prospective cohort study. BMJ Open 2012;2:e000636.
13. Duncan S, Thiong'o AN, Macharia M, et al. High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal Kenya. Sex Transm Infect 2011;87:231.
14. Mehta SD, Maclean I, Ndinya-Achola JO, et al. Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009. Antimicrob Agents Chemother 2011;55:3882-8.
15. Brown LB, Krysiak R, Kamanga G, et al. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis 2010;37:169-72.
16. Apalata T, Zimba TF, Sturm WA, et al. Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated from patients attending a STD facility in Maputo, Mozambique. Sex Transm Dis 2009;36:341-3.
17. Tobias S, Shonhiwa S, Norbert F, et al. P1-S1.10 Microbiological surveillance for sexually transmitted infections in Windhoek and Oshakati, Namibia (2007). Sex Transm Infect 2011;87:A103.
18. Gonococcal antimicrobial resistance surveillance. National Institute For Communicable Diseases Annual Review 2011-2012;p21: Http://www.nhls.ac.za/assets/ files/NICD%20Annual%20Review(1).pdf (accessed 7 Apr 2013).